Civil society organisations opposing the patent applications of US-based pharma major Gilead Sciences for the HIV drug lenacapavir have said that generic competition is needed to make the long acting ...
Novo Nordisk Global Business Services launches safe pharmaceuticals disposal initiative for employees: Our Bureau, Bengaluru Tuesday, September 17, 2024, 17:15 Hrs [IST] Novo Nord ...
Poseida Therapeutics’ P-BCMA-ALLO1 receives US FDA RMAT designation to treat relapsed/refractory multiple myeloma: San Diego Tuesday, September 17, 2024, 17:00 Hrs [IST] Poseida ...
Our Bureau, Bengaluru Tuesday, September 17, 2024, 16:30 Hrs [IST] ...
Orchid Pharma sets up Orchid AMS division, to combat the rising threat of antimicrobial resistance: Our Bureau, Bengaluru Tuesday, September 17, 2024, 16:15 Hrs [IST] Orchid Pharm ...
Initial results from dose escalation in the first in-human phase 1 trial of DS-9606 suggest early promising clinical activity in patients with advanced solid tumours known to express Claudin-6 (CLDN6) ...
FIP supports education on substandard and falsified medicines sold online with new handbook: Our Bureau, Bengaluru Tuesday, September 17, 2024, 15:50 Hrs [IST] International Pharm ...
Eppendorf India and Rajalakshmi Engineering College extend MoU to enhance biotechnology training for students: Our Bureau, ...
Accuray bridging gap of India's escalating cancer burden with latest version of Radixact radiation therapy: Our Bureau, Bengaluru Tuesday, September 17, 2024, 14:15 Hrs [IST] Accu ...
Tharimmune acquires global license and partners with Intract Pharma to develop an oral formulation of infliximab: Bridgewater, New Jersey Tuesday, September 17, 2024, 14:00 Hrs [I ...
Boehringer Ingelheim pivotal phase-III FIBRONEER-IPF study of nerandomilast meets primary endpoint: Ingelheim, Germany Tuesday, September 17, 2024, 13:00 Hrs [IST] Boehringer Inge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback